Dr. Laurence Strypstein SRL
Dr. Laurence Strypstein reported total assets of 229,405 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Mar 2026).
The score of Dr. Laurence Strypstein shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +176 % Total assets +37 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Laurence Strypstein's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 16 Mar 2026
- Year ended 30 Sep 2024filed on 07 Apr 2025
- Year ended 30 Sep 2023filed on 10 Apr 2024
- Year ended 30 Sep 2022filed on 24 Apr 2023
Dr. Laurence Strypstein's financial analysis
- Solvency95.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Laurence Strypstein
Dr. Laurence Strypstein's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.496.014
- VAT number
- BE0773496014
- Peppol
- Registered · 0208:0773496014 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Sep 2021
- Registered office
- 8500 Kortrijk
- Latest accounts
- 2025 · filed on 16 Mar 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Laurence Strypstein (SRL) has been based in Kortrijk since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 217,845 € and equity of 218,845 €; its revenue is not published. Its solvency stands at 95.4%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Laurence Strypstein
Companies in the same business, of comparable size and area, outside its group.
- Ruyckborre Manufacture of basic pharmaceutical products Ghent · balance sheet 229,421 €
- Alizee - Interface Computing infrastructure, data processing, hosting and related activities Brussels · balance sheet 229,364 €
- De Cremer Carine Haaltert · balance sheet 229,484 €
- Het Vlotgras Temse · balance sheet 229,305 €
- Upinvest Lasne · balance sheet 229,194 €
- AZ Immo Mons · balance sheet 229,376 €
- Kinequanon Ramillies · balance sheet 229,328 €
- Petra Quintens Thuisverpleging Heusden-Zolder · balance sheet 229,500 €
Frequently asked questions about Dr. Laurence Strypstein
What is the revenue of Dr. Laurence Strypstein?
Dr. Laurence Strypstein files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Laurence Strypstein?
In Belgium, the VAT number is the company number prefixed with BE: BE0773496014 for Dr. Laurence Strypstein, if the company is VAT-registered. Its company number (CBE) is 0773.496.014.
Where is the registered office of Dr. Laurence Strypstein?
According to the CBE register, the registered office of Dr. Laurence Strypstein is in 8500 Kortrijk.
What is the equity of Dr. Laurence Strypstein?
At the close of the 2025 financial year, the equity of Dr. Laurence Strypstein amounts to 218,845 €, a solvency of 95.4% of total assets.
Who manages Dr. Laurence Strypstein?
The register lists 1 active mandates at Dr. Laurence Strypstein. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Laurence Strypstein
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →